Isitalpha1.com

Visit isitalpha1.com
  • 8 months ago

    Last scanned

  • 10 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Isitalpha1.com

Visit isitalpha1.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

ZEMAIRA®: Treatment for Alpha1-Antitrypsin Deficiency | Patient Homepage

Alpha1-Proteinase Inhibitor (Human), ZEMAIRA® is indicated to raise the plasma level of alpha1-proteinase inhibitor (A1-PI) in patients with A1-PI deficiency and related emphysema.

Isitalpha1.com thumbnail
Isitalpha1.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

DNS used with this website include dbru.br.ns.els-gms.att.net, dmtu.mt.ns.els-gms.att.net.

  • 8 months ago

    Last scanned

  • 10 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

  • DNS

    dbru.br.ns.els-gms.att.net

    dmtu.mt.ns.els-gms.att.net

Whois

OWNERSHIP

  • Created

    2013-07-29

  • Expires

    2023-07-29

  • Owner

    CSL Behring LLC

  • Registar

    MarkMonitor Inc.

Domain & Keywords

The registrar of isitalpha1.com is MarkMonitor Inc. and the name expires on 2023-07-29. Owner email is not available. Their country of residence is United States of America.

  • augmentation therapy
  • alpha1-antitrypsin deficiency
  • ZEMAIRA Infusion
  • Alpha-1 treatment options

Websites similar to isitalpha1.com